期刊档案 · SUBSTANCE ABUSE

Substance Abuse-Research and Treatment

ISSN 1178-2218 · eISSN 2976-8357 · SAGE Publishing · United Kingdom

Substance Abuse-Research and Treatment 中科院 医学 4区(2025 年升级版),影响因子 1.8(官网公布),完全开放获取,APC 约 2,650 美元,近 24 个月 66 篇文章投稿到接收中位 109 天,官网公布录用率 42.7%,年发文 3 篇,ESCI、Scopus 收录。

影响因子1.8期刊官网公布的最新值
中科院分区医学 4区2025 年升级版大类
审稿周期109 天投稿到接收中位数 · 近 24 个月 66 篇文章 · PubMed
版面费2,650 USD完全开放获取
录用比例42.7%期刊官网公布
年发文量3 篇LetPub 年文章数

研究范围

研究范围与定位

Substance Abuse-Research and Treatment 由 SAGE Publishing 出版,属中科院医学大类(2025 升级版4区)。按 OpenAlex 近年发文统计,该刊主要发表 Substance Abuse Treatment and Outcomes、Opioid Use Disorder Treatment、Prenatal Substance Exposure Effects 等主题的论文,这 3 个主题约占 45.6%。(根据 OpenAlex 主题统计与中科院分区数据生成)

Journal HighlightsIndexed using ESCI, DOAJ, PsycINFO, EBSCO, PubMed Central (PMC), and ScopusPublished since 2008Publication is subject to payment of an article processing charge (APC)Substance Use: Research and Treatment is an open access, peer reviewed international focusing on human substance use research and treatment, including medical treatment and screening, mental health services, research, and evaluation of substance use programs. Please see the Aims and Scope tab for further information.This journal is a member of the Committee on Publication Ethics (COPE).Submission InformationSubmit your manuscript at https://mc.manuscriptcentral.com/sa-rt.Please see the Submission Guidelines tab for more information on how to submit your article to the journal.Open access article processing charge (APC) informationPublication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons license.The APC for this journal is $3200. The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.ContactPlease direct any queries to SAT@sagepub.com

摘自期刊官网 Aims & Scope

研究方向(LetPub):SUBSTANCE ABUSE

主编 Gregory L. Stuart出版商官网

编委会国家分布:未见中国大陆编委;主要国家 美国 30、英国 1、印度 1、意大利 1、比利时 1(共 35 位编委标注了国家) 编委会 ↗出版商官网 ·

主要研究主题 OpenAlex 近年发文统计,占比为近似值

  1. Substance Abuse Treatment and OutcomesMedicine26.3%
  2. Opioid Use Disorder TreatmentMedicine13.1%
  3. Prenatal Substance Exposure EffectsMedicine6.3%
  4. HIV, Drug Use, Sexual RiskMedicine5.8%
  5. Cannabis and Cannabinoid ResearchMedicine5.4%
  6. Smoking Behavior and CessationMedicine5%
  7. Homelessness and Social IssuesHealth Professions4.3%
  8. Neurotransmitter Receptor Influence on BehaviorNeuroscience3.7%

分区与收录

学科分区与数据库收录

中科院期刊分区表

期刊分区表( 2025年3月升级版)医学 4 区
类别学科分区
大类医学4 区
小类药物滥用SUBSTANCE ABUSE4 区

Top 期刊:否综述期刊:否

《新锐期刊分区表》( 2026年3月发布)未收录

该期刊未被此版本分区表收录。

期刊分区表( 2023年12月旧的升级版)未收录

该期刊未被此版本分区表收录。

数据库收录

ESCIScopusDOAJLetPub

国际期刊预警名单:各版本均未列入LetPub

期刊官网自述收录

PMCPsycINFO出版商官网

其他:EBSCO

期刊官网列出的收录清单,未与各数据库逐一核对;Web of Science 各子库以上方记录为准。

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。

指标

影响力指标与发文规模

影响力指标

影响因子(出版商公布)
1.8出版商官网 ·
五年影响因子(出版商公布)
1.8出版商官网 ·
CiteScore 2026-06
2.7LetPub ·
SJR 2026-06
0.83LetPub ·
SNIP 2026-06
0.77LetPub ·
h-index
42OpenAlex ·
i10-index
196OpenAlex ·
两年平均被引
0OpenAlex ·
自引率
0%LetPub ·
Gold OA 文章占比
100%LetPub ·

发文规模

年发文量(出版商公布)
3出版商官网 ·

逐年发文量 OpenAlex 统计 · 累计 383 篇 · 当年数据不完整

年份发文量其中 OA被引
20235757559
20225656640
20212929476

不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。

审稿与录用

审稿周期与录用情况

文章统计的审稿周期 PubMed 登记的稿件日期 · 至

109 天投稿到接收中位数 · P25–P75 85 天 – 144 天

接收到上线
中位数 30 天(66 篇)
投稿到上线
中位数 146 天
样本
66 篇有投稿与接收日期的文章(窗口内共 70 篇),最近一篇接收于

只统计最终被录用并发表的文章,不含被拒稿件的处理时间,因此通常长于出版商公布的"首次决定时间"。

其他来源

平均审稿速度(社区反馈)
8 WeeksLetPub ·
录用率(出版商公布)
42.7%出版商官网 ·
投稿到首次决定
5 天出版商官网 ·
接收到发表
36 天出版商官网 ·
投稿到发表(期刊自报)
约 8 周DOAJ ·
评审方式
单盲同行评审DOAJ

社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。

费用与开放获取

版面费与开放获取政策

完全开放获取DOAJ

所有文章开放获取,通常向作者收取文章处理费(APC)。

来源文章处理费费用减免许可证观测时间
DOAJUSD 2,650有CC BY、CC BY-NC
OpenAlexUSD 2,650——
LetPubUSD 2,650有—
出版商官网USD 3,200——

费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。

投稿要求

文章类型与投稿政策(官网)

接收的文章类型10 种,含篇幅限制
  1. commentaryded or discussed in the original paper. Commentary material may be peer-reviewed at the editor’s discretion Word limit: 1500 Word count includes abstract/refere…正文 ≤ 1,500 词
  2. editorialWritten by the Editor-in-Chief, deputy Editor-in-Chief or Guest Editor of a journal, editorials are intended to inform readers of changes concerning the journal…未说明篇幅
  3. letter to the editorA letter to the Editor is a brief communication that addresses the contents of a published article. Its purpose is to make corrections, provide alternative view…未说明篇幅
  4. meta-analysisView our Special Collections currently accepting submissions. Research Article Research Articles should present original work within the journal's scope, with c…未说明篇幅
  5. opinionView our Special Collections currently accepting submissions. Research Article Research Articles should present original work within the journal's scope, with c…未说明篇幅
  6. perspectiveView our Special Collections currently accepting submissions. Research Article Research Articles should present original work within the journal's scope, with c…未说明篇幅
  7. research articleView our Special Collections currently accepting submissions. Research Article Research Articles should present original work within the journal's scope, with c…未说明篇幅
  8. reviewView our Special Collections currently accepting submissions. Research Article Research Articles should present original work within the journal's scope, with c…未说明篇幅
  9. short reportShort reports present new research that adds to previous studies.未说明篇幅
  10. systematic reviewView our Special Collections currently accepting submissions. Research Article Research Articles should present original work within the journal's scope, with c…未说明篇幅
出版商官网
官网政策摘录作者资格、数据可用性、出版伦理、开放获取、同行评审、查重、预印本、试验注册 / 报告规范
作者资格 Author contributions

该期刊采用CRediT贡献者角色分类法(包含14种角色)来描述每位作者的个人贡献,投稿时需在致谢部分之后列出作者贡献。 模型中文摘要

As part of our commitment to ensuring an ethical, transparent and fair peer review and publication process, this journal has adopted CRediT (Contributor Roles Taxonomy). CRediT is a high-level taxonomy, including 14 roles, which is used to describe each author’s individual contributions to the work. You will be asked to list the contribution of each author as part of the submission process. Please…

原文 ↗出版商官网 ·
数据可用性 Data availability

期刊鼓励作者在符合伦理和法律要求的前提下,将研究数据存入公共数据仓库、提供数据可用性声明并在研究中引用数据;无法共享数据时应在声明中说明原因。 模型中文摘要

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…

原文 ↗出版商官网 ·
出版伦理 Ethical considerations

涉及人类参与者、人类数据或人体组织的研究必须声明相关伦理委员会或机构审查委员会批准或豁免审批,并提供委员会全名、所属机构及批准号;若无需伦理批准也须明确说明。 模型中文摘要

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…

原文 ↗出版商官网 ·
开放获取 Publishing fees and open access

该期刊为开放获取期刊,接受后需支付3200美元的文章处理费(由资助方、机构或作者承担),投稿本身免费。 模型中文摘要

Substance Use: Research and Treatment is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost of publishing,…

原文 ↗出版商官网 ·
同行评审 Peer review policy

该期刊实行单盲同行评审,审稿人身份对作者保密;稿件先经初步评估,不符合要求可能被退回修改或直接拒稿,之后才进入同行评审。 模型中文摘要

The following summary describes the peer review process for this journal: Identity transparency: Single Anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…

原文 ↗出版商官网 ·
查重 Plagiarism

期刊和Sage严肃对待版权侵权、抄袭及其他违反出版最佳实践的行为。 模型中文摘要

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

原文 ↗出版商官网 ·
预印本 Preprints

期刊接受曾在预印本服务器发布的稿件,投稿时需填写预印本DOI并告知编辑部,且同行评审期间不得在预印本服务器发布更新版本。 模型中文摘要

The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…

原文 ↗出版商官网 ·
试验注册 / 报告规范 Clinical trial registration

根据ICMJE要求,临床试验须在首个参与者入组时或之前在WHO认可的公共试验注册机构注册,并在摘要末尾提供注册机构名称、URL及注册号。 模型中文摘要

The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.

原文 ↗出版商官网 ·

摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。

基本信息

出版信息与官方入口

出版商
SAGE Publishing
出版国家或地区
United Kingdom
出版语言
English
ISSN
1178-2218
电子版 ISSN
2976-8357
官方链接

常见问题

关于 Substance Abuse-Research and Treatment 的常见问题

Substance Abuse-Research and Treatment 是中科院几区期刊?

2025 年升级版分区表中,Substance Abuse-Research and Treatment 为医学 4区,小类 药物滥用 4 区。不同版本与大小类分区不能混用。

Substance Abuse-Research and Treatment 的影响因子是多少?

期刊官网公布的影响因子为 1.8,属期刊自述数据,LetPub 暂无该刊的影响因子记录,CiteScore 为 2.7,h-index 为 42。

Substance Abuse-Research and Treatment 的审稿周期多长?

按 2024年10月至2026年10月(近 24 个月)66 篇已发表文章登记的日期,投稿到接收的中位数为 109 天(四分位 85–144 天);投稿社区反馈的平均审稿速度为约 8 周;期刊官网公布的录用率为 42.7%。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。

Substance Abuse-Research and Treatment 的编委会里有中国学者吗?

期刊官网编委会页面上标注了国家的 35 位编委中,没有中国大陆学者;人数最多的国家是 美国(30 位)、英国(1 位)、印度(1 位)。统计按编委会页面列出的机构国家计,仅供参考。

Substance Abuse-Research and Treatment 被哪些数据库收录?

据 LetPub 与 DOAJ 记录,Substance Abuse-Research and Treatment 被 ESCI、Scopus、DOAJ 收录。期刊官网自述还被 PMC、PsycINFO 收录,该清单未与各数据库逐一核对。

Substance Abuse-Research and Treatment 是开放获取期刊吗?版面费多少?

Substance Abuse-Research and Treatment 为完全开放获取。APC 约 2,650 美元。

来源与更新

本页事实来自 LetPub、出版商官网、OpenAlex、DOAJ;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-26 归档)。最近更新:。